Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities

NCT04167553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Obese With Comorbidities
Overweight With Comorbidities
Type2 Diabetes

Interventions

DRUG: HM15136
DRUG: Placebo

Sponsor

Hanmi Pharmaceutical Company Limited